San Diego-based Debut Biotechnology, Inc. is expanding its agreement with L’Oréal SA to develop more than a dozen “vital, bio-identical” ingredients that will replace conventionally sourced ingredients currently used in L’Oréal’s global beauty and personal-care brands across skin, hair, color cosmetics and fragrances, the firm announced on 2 July.
The company inked an agreement last summer with L’Oréal to develop “the next generation of high-performing active ingredients” for beauty and personal-care products after raising $34m in a Series B funding round led by L’Oréal’s venture capital fund BOLD
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?